As the United States seeks to maintain its status as the world’s leading economy, the acceleration of innovation becomes increasingly crucial, particularly in the face of China’s real GDP growth. A potentially significant boost to this effort lies in making research and development (R&D) tax credits transferable. This proposed change could unlock the full potential of the federal R&D tax credit system, which was originally established by Congress in 1981 to promote growth. However, the current structure of these credits has been criticized for delaying benefits and not adequately supporting the small businesses that are pivotal in driving innovation.
At present, companies can only use R&D tax credits when they have taxable income, often years after their initial R&D investment. This delay undermines the intended incentive effect. With the impending expiration of key provisions of the Tax Cuts and Jobs Act, notably the R&D expenses amortization under Section 174, Congress faces important decisions on future tax policy. It is estimated by the Committee for a Responsible Federal Budget that repealing Section 174 could cost $150 billion, while targeted relief for small businesses may require less than $25 billion, as they account for just 10% to 15% of R&D spending.
To ensure the R&D tax credit effectively promotes investment, Congress must consider businesses most likely to enhance their R&D activities. Countries like Canada, Germany, and South Korea are already offering more favorable tax environments, potentially leaving the U.S. at a competitive disadvantage in technology advancements.
The role of small businesses in innovation should not be underestimated. Large technology firms are often more focused on acquiring new technologies rather than creating them, relying on smaller companies for pioneering advancements. In this context, more effective tax policy would support small businesses, which are often financially constrained, in capitalizing on their innovative potential. Large firms such as Apple, Meta, and Microsoft possess substantial cash reserves that could support R&D activities.
If R&D tax credits were made transferable, small businesses could sell their credits to gain immediate capital, expediting research and product development. For example, a small firm investing heavily in R&D could otherwise wait several years to benefit from the tax credits. Transferability would allow the immediate realization of credits, thus providing critical funding for innovation and risk mitigation.
While some might argue that small businesses already benefit from the startup R&D payroll tax credit, this is not comprehensive enough. The existing policy’s focus on startups neglects a broader segment of small enterprises with higher survival rates, which could yield greater economic advantages if adequately supported. By contrast, the Inflation Reduction Act’s model for transferring clean energy credits provides a successful example of how such a system can enhance liquidity and drive market demand. The market for these transferable credits saw approximately $30 billion in transactions last year.
The main concern with transferability is the potential for misuse, including issues such as recapture and market manipulation. However, lessons can be drawn from existing compliance measures, such as those detailed in the Inflation Reduction Act, which utilizes certified intermediaries to ensure transparency and mitigate risks.
Accelerating when R&D credits are utilized, rather than increasing the deficit, presents an opportunity to improve business cash flow. As the U.S. aims to keep pace globally, leveraging the transformative potential of small businesses through a revised tax credit structure could significantly enhance national economic productivity. As new tax legislation looms, Congress is urged to reform the R&D tax credit, fostering innovation and economic expansion to secure the U.S.’s competitive edge in the global marketplace.